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In the middle of difficulty lies opportunity. 
Albert Einstein 
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Abstract 
 
Poor drug solubility/loading and stability, represents a problem in the development of 
drug delivery systems.  
Since ionic liquids can be placed in either lipophilic or hydrophilic solutions, they may 
be helpful to overcome these problems. Nonetheless, it is vital to determine their usefulness 
when used at concentrations were cell viability is maintained, which was considered herein. 
Five different ILs were studied - three imidazole-based ILs: [C2mim][Br], 
[C4mim][Br] and [C6mim][Br]; and two choline based ILs: [Cho][Phe] and [Cho][Glu]. Their 
cytotoxicity in human keratinocytes, their influence in drug solubility and in permeation, and 
their influence in drug release from lipidic implants, was evaluated.  
Caffeine and salicylic acid were used as model actives. Choline-based ILs proved to 
be more suitable as functional ingredients, since they showed higher impact on drug solubility 
and lower cytotoxicity. The major solubility enhancement was observed for caffeine and further 
solubility studies were carried out with this active in several concentrations of these ILs, 0.1; 
0.2; 0.5; 1.0; 3.0 and 5.0%, w/w, at 25 C and 32 C. Solubility was greatly influenced by 
concentrations up to 0.5%. The choline-based ILs showed no significant impact on the skin 
permeation, for both actives. For the imidazole-based ILs the size of the alkyl chain enhances 
the caffeine solubility and permeation, but also the ILs cytotoxicity, limiting their use.  
O/W emulsions and gels were prepared containing the less toxic choline-based ILs and 
caffeine. All prepared formulations were stable. Lipidic implants containing IL and salicylic 
acid were also successfully prepared.  
Our results indicate that the choline-based ILs were effective functional ingredients, 
since, when used at non-toxic concentrations, they allowed a higher drug loading, in topical 
formulations, while maintaining their stability, and allowed a higher drug release from lipidic 
implants. 
 
Keywords: Ionic Liquids; solubility enhancement; pig skin permeation; cytotoxicity; 
drug delivery systems  
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Resumo 
 
A baixa solubilidade/incorporação e estabilidade de alguns fármacos, representa um 
problema no desenvolvimento de sistemas de veiculação de fármacos. 
Como os líquidos iónicos, LI, podem ser colocados em soluções lipofílicas ou 
hidrófilas, podem ser úteis para superar estas dificuldades. No entanto, é crucial determinar a 
sua utilidade em quantidades onde se mantenha a viabilidade celular, facto que foi considerado 
neste estudo. 
Cinco LI diferentes foram estudados - três LI derivados de imidazol: [C2mim][Br], 
[C4mim][Br] e [C6mim][Br]; e dois LI derivados da colina: [Cho][Phe] e [Cho][Glu]. Foi 
avaliada a sua citotoxicidade, a sua influência na solubilidade e na permeação cutânea dos 
fármacos estudados e a sua influência na libertação de fármacos a partir de implantes lipídicos. 
A cafeína e o ácido salicílico foram utilizados como ativos modelo. Os LI derivados 
da colina revelaram-se mais adequados como ingredientes funcionais, dado apresentarem maior 
impacto na solubilidade do fármaco e uma menor citotoxicidade. O maior aumento de 
solubilidade foi observado para a cafeína, tendo sido realizados outros estudos de solubilidade 
com este ativo em várias concentrações desses LI, 0,1; 0,2; 0,5; 1,0; 3,0 e 5,0%, m/m, a 25 °C 
e 32 °C. A solubilidade foi fortemente influenciada nas concentrações até 0,5 %. Os LI 
derivados de colina não mostraram um impacto significativo na permeação de nenhum dos 
fármacos. Para os LI derivados de imidazol, o tamanho da cadeia de alquilo aumenta a 
solubilidade e permeação da cafeína, mas também a citotoxicidade do LI, limitando seu uso. 
As emulsões A/O e geles foram preparados contendo os LI menos tóxicos, derivados 
de colina, e a cafeína. Todas as formulações preparadas foram estáveis. Os implantes lipídicos, 
contendo LI e ácido salicílico, também foram preparados com sucesso. 
Os resultados indicam que os LI derivados de colina eram ingredientes funcionais 
efetivos, pois quando utilizados em concentrações não tóxicas, permitiram um aumento da 
concentração de fármaco, em formulações tópicas, mantendo sua estabilidade e permitiram uma 
maior liberação de fármaco a partir de implantes lipídicos. 
Palavra-Chave: Líquidos Iónicos; promoção da solubilidade; permeação em pele de 
porco; sistemas de veiculação de fármacos.  
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
6 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
List of abbreviations and acronyms 
 
% V/V  Percentage volume by volume 
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%   Percentage 
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FDA   Food and Drug Administration 
g   Gram 
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M   Molar 
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mins   Minute  
MIP   Isopropyl myristate 
mL   Millilitres 
mmol  Millimole 
mPa.s  Millipascal-second 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium 
bromide 
n   Number of samples 
nm   Nanometres 
O/W   Oil in water 
PBS   Phosphate-buffered saline 
PEG 400  Polyethylene glycol 400 
PT Group  Pharmacology and Therapeutics Group 
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q.s.   Quantity sufficient 
RT   Room Temperature 
SD   Standard deviation 
USA   United States of America 
USP 32  United States Pharmacopeia 32 
UV   Ultraviolet radiation 
x g   Times gravity 
λ   Maximum absorption wavelength 
 
 
 
  
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
9 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
General Index 
 
TABLES INDEX ........................................................................................................................................11 
FIGURES INDEX .....................................................................................................................................12 
 
1. INTRODUCTION .............................................................................................................................14 
2. MATERIALS AND REAGENTS ................................................................................................19 
2.1. MATERIALS ........................................................................................................... 19 
2.2. REAGENTS ............................................................................................................. 20 
3. METHODS ..........................................................................................................................................22 
3.1. SYNTHESIS OF IONIC LIQUIDS .............................................................................. 22 
3.2. SOLUBILITY STUDIES ........................................................................................... 22 
3.3. PERMEATION STUDIES.......................................................................................... 23 
3.4. CYTOTOXICITY OF IONIC LIQUIDS ....................................................................... 23 
3.5. GRAVIMETRIC STUDIES: PERCENTAGE OF IMIDAZOLE-BASED ILS THAT 
PERMEATED THE SKIN ..................................................................................... 24 
3.6. PREPARATION OF TOPICAL FORMULATIONS ...................................................... 24 
3.6.1. O/W Emulsions ................................................................................ 24 
3.6.2. Gels ................................................................................................... 26 
3.7. ACCELERATED STABILITY STUDIES OF THE TOPICAL FORMULATIONS ............ 26 
3.7.1 Centrifuge Test .................................................................................. 27 
3.7.2 Temperature Cycles ........................................................................... 27 
3.8. MICROSCOPIC ANALYSIS ..................................................................................... 27 
3.9. LIPIDIC IMPLANTS ................................................................................................ 27 
3.9.1 Implants Preparation.......................................................................... 28 
3.9.2 Content Uniformity ........................................................................... 28 
3.9.3 In vitro Drug Release ........................................................................ 29 
3.9.4 Drug Content ..................................................................................... 29 
3.10. STATISTICAL ANALYSIS........................................................................................ 29 
 
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
10 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
4. RESULTS AND DISCUSSION ....................................................................................................30 
4.1. SOLUBILITY STUDIES ........................................................................................... 31 
4.2. PERMEATION STUDIES.......................................................................................... 33 
4.3. IONIC LIQUIDS CYTOTOXICITY ............................................................................ 35 
4.4. GRAVIMETRIC STUDIES: DETERMINATION OF PERCENTAGE OF IMIDAZOLE-
BASED ILS THAT PERMEATED THE SKIN......................................................... 36 
4.5. TOPICAL FORMULATIONS: PREPARATION AND STABILITY STUDIES ................ 37 
4.5.1. O/W Emulsions .................................................................................... 37 
4.5.2. Gels ...................................................................................................... 38 
4.6. MICROSCOPIC ANALYSIS ..................................................................................... 39 
4.7. LIPIDIC IMPLANTS ................................................................................................ 40 
4.7.1. Content Uniformity .............................................................................. 41 
4.7.2. In Vitro Drug Release .......................................................................... 41 
4.7.3. Drug Content ........................................................................................ 43 
5. CONCLUSION ..................................................................................................................................44 
6. REFERENCES ...................................................................................................................................46 
7. GLOSSARY ........................................................................................................................................52 
8. SCIENTIFIC OUTPUTS ................................................................................................................53 
ARTICLES ......................................................................................................................... 53 
ORAL COMMUNICATIONS ............................................................................................... 53 
POSTERS. .......................................................................................................................... 54 
 
APPENDIX .................................................................................................................................................... I 
 APPENDIX I: 1H-NMR SPECTRUMS OF THE SYNTHETIZED CHOLINE-
BASED ILS ................................... ……………………………………………………………………………………………II 
 APPENDIX II: PHYSICAL AND CHEMICAL PROPERTIES OF THE MODEL 
DRUGS ......................................................................................................................................... III 
 
 
  
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
11 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
Tables Index 
 
Table 1: Qualitative and quantitative composition, % w/w, for O/W emulsions with 
and without caffeine and/or [Cho][Phe]. ............................................................... 25 
 
Table 2: Qualitative and quantitative composition, % w/w, for O/W emulsions with 
and without caffeine and/or [Cho][Glu]. ............................................................... 25 
 
Table 3: Qualitative and quantitative composition, % w/w, for gels with and without 
caffeine and/or the choline-based ILs. ................................................................... 26 
 
Table 4: Composition, % w/w, for the Lipidic Implants with and without Salicylic 
Acid and/or the [Cho][Phe] IL. .............................................................................. 28 
 
Table 5: Caffeine solubility in water or water:ILs mixtures, 99.8:0.2 % w/w, at 25 C 
and 32 C.  n=3, mean ± SD. ................................................................................. 33 
 
Table 6: Percentage, %, of imidazole-based ILs that permeated the skin. n=3 and mean 
± SD. ...................................................................................................................... 37 
 
Table 7: Temperature cycles, n=3, for the O/W emulsions. ...................................... 38 
 
Table 8: pH and viscosity of the gels with and without caffeine and/or the choline-
based ILs. ............................................................................................................... 39 
 
  
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
12 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
Figures Index 
 
Figure 1: A. Dialkylimidazolium and B. Alkylammonium cations contained in the ILs 
used herein. ............................................................................................................ 15 
 
Figure 2: Caffeine Structure. ..................................................................................... 16 
 
Figure 3: Salicylic Acid Structure ............................................................................. 17 
 
Figure 4: Structure of the studied ILs. ....................................................................... 30 
 
Figure 5: A. Caffeine and B. Salicylic acid solubility in water or water:IL mixtures, 
95:5, % w/w, at 25 C and 32 C. n=3, mean ± SD and * p<0.05, ** p<0.01, *** 
p<0.001 in ANOVA, Tukey’s Test........................................................................ 31 
 
Figure 6: Caffeine solubility in different concentrations, % w/w, of the choline-based 
ILs at 25 C. n=3, mean ± SD. ............................................................................... 32 
 
Figure 7: Caffeine solubility in different concentrations, % w/w, of the choline-based 
ILs at 32 C. n=3, mean ± SD. ............................................................................... 32 
 
Figure 8: Relative permeation flux of saturated solutions of A. Caffeine and B. 
Salicylic acid in water or water:IL mixtures, 95:5 % w/w. 3 < n < 5, mean ± SD and 
**p<0.01 and ***p<0.001 with ANOVA, Tukey’s test. ....................................... 34 
 
Figure 9: Cell viability of HaCat cells exposed to halogenated ILs during 24 h of 
incubation, MTT assay. Results are presented as mean ± SD, n=2. ...................... 35 
 
Figure 10: Cell viability of HaCat cells exposed to choline-based ILs during 24 h of 
incubation, MTT assay. Results are presented as mean ± SD, n=2. ...................... 35 
 
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
13 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
Figure 11: Microscopic analysis of O/W emulsions with and without caffeine and/or 
the IL: A. [Cho][Phe]; B.[Cho][Glu]. Arrows point to visible caffeine crystals. 
Scale bar = 100 µm. ............................................................................................... 40 
 
Figure 12: Lipidic Implants with 2.5 % w/w of A. Sudan III or B. Methylene Blue.
 ............................................................................................................................... 41 
 
Figure 13: Effect of implants composition on drug release, mean ± SD and n=5. ... 42 
 
Figure 14: Drug content of the prepared implants with A. Dynasan 118, B. Dynasan 
118:IL, C. Dynasan 118:Gelucire 50/02, D. Dynasan 118:Gelucire 50/02:IL, E. 
Dynasan 118:Sucrose and F. Dynasan 118:Gelucire 50/02:IL. n=3 and mean ± SD. 
Statistically analysed by ANOVA, Tukey’s test. .................................................. 43 
 
Figure 15: 1H NMR Spectrum of the synthetized [Cho][Glu]. ................................... ii 
 
Figure 16: 1H NMR Spectrum of the synthetized [Cho][Phe]. ................................... ii 
 
 
 
  
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
14 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
1. Introduction 
 
The Pharmaceutical Industry spends a great amount of their financial resources in drug 
development, to improve the safety and efficacy of the developed drugs. Additionally, to 
overcome weaknesses such as poor drug solubility/loading and release, and reduced stability, 
amongst others, it is also crucial for the pharmaceutical field to develop new and more efficient 
Drug Delivery Systems, DDS (Almeida, Júlio, Mota, Rijo, & Reis, 2017; Tiwari et al., 2012). 
DDS are formulations or devices that introduce the drug in the body, increase the 
efficacy and safety of the drug, and control the rate, time and place of its release. Hence, DDS 
are considered an interface between the drug and the body (Jain, 2008). These systems are also 
used to solve some non-ideal properties of drugs that interpose with their therapeutic 
implications, such as poor solubility and biodistribution, unfavorable pharmacokinetics, tissue 
damage on extravasation, rapid breakdown of the drug in vivo and low selectivity for target 
tissues (Allen, 2004). Additionally, some DDS have limited stability, which represents an 
additional challenge. Because of these difficulties, several strategies have been made to develop 
new and/or more efficient DDS, as well as to find new functional ingredients that may increase 
drug solubility, loading, permeation and stability.  
In this sense, some ionic liquids, ILs, may be potential candidates as solvents, or even 
as vehicles, in DDS to solve or minimize these problems, since they are substances that may be 
introduced in water, oils or alcoholic solutions, due to their peculiar characteristics, arising from 
their structures. In our days, some studies have already shown the use of ILs to enhance drug 
solubility, permeation and stability (Almeida et al., 2015; Dobler, Schmidts, Klingenhoefer, & 
Runkel, 2012; Frade & Afonso, 2010; Frizzo et al., 2013; Hough et al., 2007; Mizuuchi, Jaitely, 
Murdan, & Florence, 2008; Stoimenovski, MacFarlane, Bica, & Rogers, 2010). 
ILs are salts in which ions, an organic cation and an organic or inorganic anion, are 
poorly coordinated, resulting in solvents that are liquid below 100 °C or even at room 
temperature, RT. Furthermore, ILs have key properties, like high thermal and chemical 
stability, low vapour pressure, nonflammability, negligible volatile and re-usability (Almeida 
et al., 2015; Earle et al., 2006; Ghandi, 2014; Kubota, Shibata, & Yamaguchi, 2016). Depending 
on the type of ions used, the ILs can be miscible, immiscible or partially miscible with water, 
so by changing their chemical structure we can adjust the solvent characteristics of these salts 
(Czekanski, Santos de Almeida, Portugal Mota, Rijo, & Araújo, 2014; Gouveia et al., 2014). 
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Most importantly, the high suitability of these salts for alterations, allows the modification of 
their overall properties (Ghandi, 2014). 
As a consequence of the above mentioned properties, these salts have been used in the 
Pharmaceutical Industry with different purposes, namely as extractants of pharmaceutical 
compounds from aqueous solutions (Álvarez, Esperança, Deive, Sanromán, & Rodríguez, 
2015; Marrucho, Branco, & Rebelo, 2014; Mitkare, Lakhane, & Kokulwar, 2013), as solubility 
promotors (Marrucho et al., 2014) and as solvents and catalysts of active pharmaceutical 
ingredients, APIs (Marrucho et al., 2014; Shamshina, Barber, & Rogers, 2013). Also, some 
studies have used ILs as oil or water substitutes, as additives or as surfactants in emulsions and 
micro emulsions (Dobler et al., 2012; Lawrence & Rees, 2000; Qiu & Texter, 2008; Zech et al., 
2009; Zhu et al., 2009). Hence, there are multiple and valuable uses for these salts. 
ILs may be divided in four categories depending on the cation present in their 
composition: either a dialkylimidazolium cation, an N-alkylpyridinium cation, an 
alkylammonium cation or a phosphonium cation (Almeida et al., 2017). Nonetheless, since the 
imidazole-based ILs are amongst the most studied ILs and the choline-based ILs have been 
considered less toxic (Gouveia et al., 2014) this study focus on these two particular classes of 
ILs, shown in Figure 1, and in their applicability as functional ingredients in DDS.  
 
 
Figure 1: A. Dialkylimidazolium and B. Alkylammonium cations contained in the ILs used herein. 
 
 The reason why Imidazole-based ILs are amongst the most studied ILs, is due to their 
lower viscosity and to the stability of the imidazolium cation in oxidative and reductive 
conditions. Hence, they have been used for several applications, such as solvents and catalysts 
in synthesis and as solubility enhancers in DDS. In terms of their use as solubility promoters, 
their cytotoxicity may represent a drawback, particularly for those ILs with a long alkyl chain 
attached to the imidazolium cation and this should always be considered (Almeida et al., 2017). 
A. B. 
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On the other hand, some choline based ILs, derived from amino acids, have been 
described has less toxic (Gouveia et al., 2014) and consequently they may be more suited to 
incorporate in DDS. These ILs have choline as a cation and different amino acids as the anion. 
Choline is an essential micronutrient for cells and the amino acids are nontoxic, biocompatible 
and biodegradable compounds and that is why these ILs are less toxic and more biodegradable 
and biocompatibility than other ILs not derived from non-renewable sources. In terms of their  
applicability, they have also been used as solvents and catalysts in synthesis (De Santis et al., 
2015; Gouveia et al., 2014). Nonetheless, in terms of their utility in DDS, their utility at 
different concentrations and their incorporation in formulations at non-toxic concentrations 
needs to be considered. 
To evaluate the influence of the studied Ionic liquids on drug solubility, loading and 
realise, to active models, widely used in the pharmaceutical field, have been used in this study, 
caffeine as a hydrophilic model and salicylic acid as a more lipophilic model. 
Caffeine, 1,3,7-trimethylpurine-2,6-dione (Pubchem: Open chemistry database, n.d.-
a), which structure is shown in Figure 2, is a natural methylxanthine alkaloid that may act, as 
a mild stimulant of the central nervous system (Ferré, 2016), as an alertness and agitation 
promotor in systemic uses, as a cosmetologically active ingredient to prevent accumulation of 
fat in cells and as an antioxidant (Herman & Herman, 2012). Since caffeine, during lipolysis, 
stimulates the fats cells degradation by the inhibition of the phosphodiesterase activity, by the 
stimulation of β-adrenergic receptors and by the increase of cyclic adenosine monophosphate 
levels, it has the capacity to act as an anti-cellulite substance (Herman & Herman, 2012; Lupi, 
Semenovitch, Treu, Bottino, & Bouskela, 2007; Velasco et al., 2008). On the other hand, its 
antioxidant capacity is due to the ability to protect cells against the UV radiation, which slows 
the photoaging process of the skin (Herman & Herman, 2012). The antioxidant capacity of 
caffeine  comes from its ability to improve the cellular redox status followed by increasing the 
levels of intracellular glutathione (Jung, Kim, Park, Jeong, & Ko, 2017; Vignoli, Bassoli, & 
Benassi, 2011). 
 
Figure 2: Caffeine Structure (Pubchem: Open chemistry database, n.d.-a). 
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 Hence, because caffeine has several characteristics useful for both the pharmaceutical 
and the cosmetic fields and since it is a relatively accessible drug it has been widely used as 
active model and that is why it was chosen in this present study as a more hydrophilic drug 
model. 
On the other, Salicylic acid, 2-hydroxybenzoic acid (Pubchem: Open chemistry 
database, n.d.-b), which structure is shown in Figure 3, will be used as a more lipophilic active 
model.  
 
Figure 3: Salicylic Acid Structure (Pubchem: Open chemistry database, n.d.-b). 
 
This drug is a natural β-hydroxy acid that has been used for the treatment of acne, 
psoriasis, callouses, corns, keratosis pilaris and warts, since it acts as bacteriostatic, keratolytic 
agent and chemical peeling agent (Arif, 2015). As a keratolytic agent in callouses and keratosis 
pilares, it may disrupt cellular junctions and break or lyse intercellular keratin filaments (Arif, 
2015). In the chemical peeling, salicylic acid does a exfoliation of the superficial layers of the 
skin, which promotes the skin and dermal tissues regeneration (Arif, 2015). When salicylic acid 
acts as peeling agent in the acne and psoriasis, its application is improved by the combination 
of phototherapy or pulsed dye laser (Alba, Gerenutti, Yoshida, & Grotto, 2017; Arif, 2015; 
Lekakh et al., 2015). It has also been described has acting as an anti-inflammatory drug (Arif, 
2015; Klessig, Tian, & Choi, 2016). Furthermore, this drug is the active metabolite of the acetyl 
salicylic acid, that is used for pain, fever and inflammation (Klessig, Tian, & Choi, 2016).  
Hence, both chosen actives have many different applications in the pharmaceutical and 
cosmetic field that justify their choice as models for this study.  
Therefore, herein five ILs, three imidazole-based ILs — [C2mim][Br], [C4mim][Br] 
and [C6mim][Br] — and two choline-based ILs —[Cho][Phe] and [Cho][Glu]. [Cho][Phe] and 
[Cho][Glu] were studied and synthetized as drug solubility and/or permeation enhancers 
(Almeida et al., 2015; Gouveia et al., 2014).  
Finally, one of the focus of this study was to evaluate if the synthesized ILs could act 
as drug solubility, loading and/or release enhancers, at concentrations were cell viability is 
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maintained, since this is crucial to confidently assert that these salts may act as functional 
ingredients in Drug Delivery Systems. For this purpose, the cytotoxicity of the prepared ILs 
was performed in human keratinocytes, HaCaT cells. Then, considering the cytotoxicity results, 
different delivery systems were prepared containing nontoxic concentrations of the ILs and         
2% w/w of the active. So, Oil-in-Water, O/W, emulsions and gels containing the active and the 
IL were prepared and the stability of the prepared formulations was evaluated.  
Furthermore, to assess the influence of ILs on the drug release of a more lipophilic 
drug from subcutaneous systems, lipidic implants containing salicylic acid and an IL were also 
prepared. The influence of the IL on the drug content and release was then evaluated.  
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2. Materials and Reagents 
 
2.1. Materials 
 
▪ Analytical scale Sartorius BP221S® 
▪ Centrifuge Jouan BR 4i® 
▪ Common laboratory material 
▪ Desiccator 
▪ Freezer Omina® 
▪ Glass Franz type diffusion cells 
▪ Heating plate with stirring 
▪ Horizontal shaker IKA-Vibrax-VWR® 
▪ Incubator Heidolph 1000® with Stirring Heidolph Unimax 1010®  
▪ Inverted microscope OLYMPUS CKX41® with Camera OLYMPUS SC20®  
▪ Lyophilizer LABCONCO FreeZone 25® 
▪ Magnetic stirrer 
▪ Micropipette P100, P200, P1000 and P5000 VWR Ergonomic High-Performance® 
▪ Minivortex MS2 IKA® 
▪ Multi-point plate 
▪ Oven Memmert U30® 
▪ pH meter 827 pH lab Metrohm® 
▪ Rotary Evaporator with bath IKA Labortechnik HB4 basic® and Elevator IKA 
WERKE RV06-ML® Thermostatic water bath Memmert® 
▪ Ultrasounds Bandolin Sonorex Super RK 510 H® 
▪ UV-visible spectrophotometer Evolution 300 UV-Vis—Thermo Scientific® 
▪ Viscometer Brookfield® 
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2.2. Reagents 
 
▪ Acetone 
▪ Acetonitrile by Sigma-Aldrich, USA 
▪ Butylated hydroxytoluene, BHT, by Mapric, Brazil 
▪ Caffeine anhydrous by Fagron, Spain 
▪ Carbopol® 940 by José Vaz Pereira, Portugal 
▪ Cholinium hydroxide in methanol [Cho][OH]/MeOH 45 % by Sigma-Aldrich, USA 
▪ Crodafos CES®, cetearyl alcohol and diacetyl phosphate and ceteth-10 phosphate, 
by Mapric, Brazil 
▪ Deionized water 
▪ Diethyl ether by Panreac, Spain 
▪ Dynasan® 118, Glycerin triestearate, by Cremer Oleo GmbH, Germany 
▪ Ethylenediaminetetraacetic acid disodium, Disodium EDTA, by Fagron, Spain 
▪ Gelucire® 50/02, mixture of monoesters, di-esters and tri-esters of glycerol and 
mono- and di-esters of polyethylene glycol, by GatteFossé, France 
▪ Isopropyl myristate, MIP, by Pharma Special, Brazil 
▪ L-glutamine by Sigma-Aldrich, USA 
▪ L-phenylalanine by Sigma-Aldrich, USA 
▪ Methanol by Sigma-Aldrich, USA 
▪ Methylene blue 
▪ Methylparaben by Sigma-Aldrich, USA 
▪ Nitric acid by VWR, USA 
▪ Polyethylene glycol 400, PEG 400, by Panreac, Spain 
▪ Propylene glycol by Fagron, Spain 
▪ Propyl paraben by Sigma-Aldrich, USA 
▪ Salicylic acid by Sigma-Aldrich, USA 
▪ Silver Nitrate by Sigma-Aldrich, USA 
▪ Sodium azide by Sigma-Aldrich, USA 
▪ Sodium Chloride by Sigma-Aldrich, USA 
▪ Sodium phosphate dibasic dihydrate by Sigma-Aldrich, USA 
▪ Sodium phosphate monobasic dihydrate by Sigma-Aldrich, USA 
▪ Sucrose 
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▪ Sudan III 
▪ Triethanolamine by José Vaz Pereira, Portugal  
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3. Methods 
 
3.1. Synthesis of Ionic Liquids 
 
The imidazole-based ILs, 1-ethyl-3-methylimidazolium bromide [C2mim][Br],                     
1-butyl-3-methylimidazolium bromide [C4mim][Br] and 1-hexyl-3-methylimidazolium 
bromide [C6mim][Br], were kindly provided by a collaboration with the Centro de Química e 
Bioquímica, CQB, of Faculdade de Ciências da Universidade de Lisboa. 
The two amino acid derivative ILs, (2-hydroxyethyl)-trimethylammonium-L-
phenylalaninate [Cho][Phe] and (2-hydroxyethyl)-trimethylammonium-L-glutamate 
[Cho][Glu], were prepared according to the literature (Czekanski et al., 2014; Gouveia et al., 
2014) with slight modifications. Briefly, 15.6 mL of cholinium hydroxide in methanol 
[Cho][OH]/MeOH 45 % was evaporated under vacuum, on the Rotary Evaporator with bath 
IKA Labortechnik HB4 basic® and Elevator IKA WERKE RV06-ML®, at 50 C. Furthermore, 
it was added an aqueous solution of 57.79 mmol of amino acid, the solution was already 
prepared with the minimum amount of water necessary to completely solubilize the amino acid. 
The mixture was stirred in an ice bath for 17h and it was evaporated on the rotary evaporator at 
60 °C. Next, it was added a mixture of acetonitrile:methanol, 9:1 with vigorously stirring for 
amino acid in excess on the solution to precipitate. To remove the solid, a gravity filtration was 
made simultaneously, followed by centrifugation at 10 080 x g, for 20 mins and by vacuum 
evaporation at 60 °C, to remove the solvent (Santos de Almeida et al., 2017). The prepared ILs 
were stored, and conserved without light, in a desiccator.  
 
3.2. Solubility Studies 
 
Solutions of caffeine and salicylic acid were saturated and they were prepared in 
triplicate in deionized water and several mixtures of deionized water:IL. After that, saturated 
solutions were placed in a horizontal shaker, at 0.5 x g, at 25 ± 2 °C, RT, and 32 ± 2 °C, skin 
surface temperature, for 72 h. After being filtered to gravity to remove the solute in excess, all 
samples were analyzed by UV-visible spectrophotometry, at wavelength of maximum 
absorption for caffeine, 273 nm, and salicylic acid, 278 nm, in water. 
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3.3. Permeation Studies 
 
Permeation studies, n=5, were carried out in glass Franz type diffusion cells with a 
receiver volume of approximately 4 mL and a diffusion area of 0.95 cm2, using pig ear skin. 
The porcine ears were gently provided from a local slaughterhouse, Suinimais Lda, Leiria, 
Portugal. This skin is previously prepared by shearing, carefully, not to damage the stratum 
corneum, followed by separation of the epidermis existing cartilage in the outer part of the ear, 
using a scalpel. Previously, to remove impurities the ear was washed with tap and deionized 
water. After these processes, the skin is kept in the freezer at -20 °C, until it was used (Santos 
de Almeida et al., 2017).  
Furthermore, 500 µL of the active compound saturated solutions, in a water:IL 
mixture, with a ratio of 95:5, was placed in the donor compartment. This compartment was 
occluded by sealing it with microscope coverslips. The receptor compartment was filled with a 
medium, phosphate-buffered saline, PBS, pH 7.4, and was placed in a thermostatic bath at          
37 °C, to ensure that it was at 32 °C.  
The full content of the receptor compartment was collected and simultaneously 
replaced with fresh and preheated medium at pre-determined intervals. Quantitative analysis of 
the medium was done by using UV-visible spectrophotometry. The determination of the 
active’s steady state flux was made by monitoring the cumulative amount of drug diffusing and 
measuring the slope of the graph once steady-state diffusion was reached. 
 
3.4. Cytotoxicity of Ionic Liquids 
 
The cytotoxicity of choline-based ILs was characterized in human keratinocytes, 
HaCaT cells line, by MTT assay, according to previously published literature (Fernandes et al., 
2010; Wagemaker et al., 2015). Different concentrations of ILs were tested between 0.01 and 
1.0 % V/V, with an incubation period of 24 h. This study was accomplished by the 
Pharmacology and Therapeutics Group, PT Group, from Research Center for Biosciences & 
Health Technologies, CBIOS. 
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3.5. Gravimetric studies: Percentage of imidazole-based ILs 
that permeated the skin 
 
To quantify the amount of halogenated ILs that permeated the porcine ear, contained 
in the caffeine saturated solutions, gravimetric studies of the samples collected from the 
receptor compartment, were performed. 
The assay was done in triplicate and a mass of 0.03 g of the sample was weighed. 
Then, 13.5 mL of deionized water and 0.075 mL of aqueous solution of nitric acid 6 M were 
added. This solution was stirred and 4.5 mL of an aqueous solution of silver nitrate 0.125 M 
was the added. Afterwards, the solution was gently warmed and then cooled to RT, followed 
by gravity filtration, with a previously weighed fluted paper filter. The paper filter was washed 
with two portions of 0.75 mL of deionized water and three portions of 0.75 mL of acetone. 
Then, the paper filter was placed to dry in the oven at 60 °C for one night and after that it was 
removed and placed in the desiccator. The quantification was made by weighing the solid mass 
which was retained on the paper filter, with successive daily weighing’s until three consecutive 
equal weights were obtained (Nelson, 1985). 
 
 
3.6. Preparation of Topical Formulations 
 
 
3.6.1. O/W Emulsions 
 
The composition of the emulsions is shown in Tables 1 and 2. In the preparation of 
the O/W emulsions, the raw materials of the aqueous and oily phases were weighed. Both 
phases were placed in a thermostat bath at 65 °C to melt the oily phase, while at the same time 
the temperature of the two phases was equalized. Then, the aqueous phase was added to the oil 
phase, still in the bath and always with vigorous stirring. Finally, the mixture was removed from 
the bath under continuous stirring until the temperature decreased to RT and the emulsion 
appeared homogeneous. 
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Table 1: Qualitative and quantitative composition, % w/w, for O/W emulsions with and without caffeine and/or 
[Cho][Phe]. 
Compound 
O/W Emulsions 
Without 
caffeine/IL 
With caffeine and 
without IL 
With caffeine 
and IL 
Crodafos CES® 4 4 4 
MIP 2 2 2 
BHT 0.1 0.1 0.1 
Disodium EDTA 0.1 0.1 0.1 
Propylene Glycol 5 5 5 
PEG 400 5 5 5 
Concentrate parabens 1 1 1 
Caffeine - 2 2 
[Cho][Phe] - - 0.2 
Triethanolamine q.s. to pH=4-6 q.s. to pH=4-6 q.s. to pH= 4-6 
Deionized water q.s. 100 q.s. 100 q.s. 100 
 
 
Table 2: Qualitative and quantitative composition, % w/w, for O/W emulsions with and without caffeine and/or 
[Cho][Glu]. 
Compound 
O/W Emulsions 
Without 
caffeine/IL 
With caffeine and 
without IL 
With caffeine 
and IL 
Crodafos CES® 6 6 6 
MIP 2 2 2 
BHT 0.1 0.1 0.1 
Disodium EDTA 0.1 0.1 0.1 
Propylene Glycol 5 5 5 
PEG 400 5 5 5 
Concentrate parabens 1 1 1 
Caffeine - 2 2 
[Cho][Glu] - - 0.2 
Triethanolamine q.s. to pH=4-6 q.s. to pH=4-6 q.s. to pH= 4-6 
Deionized water q.s. 100 q.s. 100 q.s. 100 
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3.6.2. Gels 
 
These formulations were also prepared in the presence and absence of ILs. The 
composition of the gels is shown in Table 3. Once again, all the raw materials were weighed 
and the deionized water and IL were placed in a flask. Then, the active was dissolved with 
stirring. When the drug was fully dissolved, the parabens concentrate and propylene glycol 
were added to the mixture. Finally, under vigorous stirring, the Carbopol® 940 was also added 
and the stirring was continued until a completely homogeneous formulation was attained. 
 
Table 3: Qualitative and quantitative composition, % w/w, for gels with and without caffeine and/or the choline-
based ILs. 
Compounds 
Gels 
Without 
caffeine/IL 
With 
caffeine 
and 
without IL 
Without 
caffeine 
and with 
IL 
With 
caffeine/IL 
Carbopol® 940 0.5 0.5 0.5 0.5 
Propylene Glycol 5 5 5 5 
Concentrate parabens 1 1 1 1 
Caffeine - 2 - 2 
[Cho][Phe] or [Cho][Glu] - - 0.2 0.2 
Triethanolamine q.s. pH=5 q.s. pH=5 q.s. pH=5 q.s. pH=5 
Deionized water q.s. 100 q.s. 100 q.s. 100 q.s. 100 
 
 
3.7. Accelerated Stability Studies of the Topical 
Formulations 
 
Organoleptic characteristics, pH and viscosity of all topical formulations were 
analysed at time zero and after 5 days. The prepared emulsions and gels were challenged with 
a centrifuge test and temperature cycles. 
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3.7.1 Centrifuge Test 
 
In the centrifugation test, n = 3, approximately 5 g of each formulation was weighed 
and heated at 45 °C for 30 mins. Then, the samples were centrifuged for 30 mins at 7 200 x g. 
 
3.7.2 Temperature Cycles 
 
For the temperature cycles, n=3, the freeze-thaw stability was evaluated using 24 h 
temperatures cycles between -4 °C and 45 °C for 5 days. 
 
 
3.8. Microscopic Analysis 
 
Instability phenomena and the presence/absence of active crystals, in all the prepared 
emulsions with and without drug and/or IL, were analyzed by contrast phase microscopy. 
Briefly, an aliquot of emulsion was spread between a cover slip and a glass slide. The images 
were obtained using an OLYMPUS SC20 camera coupled to an inverted OLYMPUS CKX41 
microscope with a 40x objective (Cerqueira, 2014). 
 
 
3.9. Lipidic Implants 
 
In previous studies our group has evaluated the incorporation of caffeine and ILs in 
lipidic implants (Antunes, 2015). Herein, the incorporation of the more lipophilic salicylic acid 
in lipidic implants, in the presence and absence of ILs, was also evaluated. 
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3.9.1 Implants Preparation 
 
The lipidic implants were prepared by fusion and melding according the method of 
Kreye et al. with a few modifications (Antunes, 2015; Kreye, Siepmann, & Siepmann, 2008).  
Briefly, the solid lipid was heated in a Becker with a water bath until melting. Drug, 
previously sprayed and sieved with a diameter under 100 µm, was added to the lipid, with 
continuous stirring, until its complete dispersion in the fused lipid. The fused lipid:drug mixture 
was pipetted with a sterile disposable plastic pipette. After cooling to RT, the implants were 
withdrawn from the pipette and stored in the desiccator to remove a possible excess of water. 
Before being used the implant was cut to the required size. The lipid:drug ratio in all prepared 
implants was 90:10, % w/w. The implants composition is described in Table 4. 
 
Table 4: Composition, % w/w, for the Lipidic Implants with and without Salicylic Acid and/or the [Cho][Phe] IL. 
Formulations 
% w/w 
Dynasan 118 Gelucire 50/02 Sucrose Ionic Liquid Drug 
A 90.0 - - - 
10 
B 89.8 - - 0.2 
C 80.0 10.0 - - 
D 79.8 10.0 - 0.2 
E 80.0 - 10.0 - 
F 79.8 - 10.0 0.2 
G 100.0 - - - 
- 
H 99.8 - - 0.2 
I 90.0 10.0 - - 
J 89.8 10.0 - 0.2 
K 90.0 - 10.0 - 
L 89.8 - 10.0 0.2 
 
3.9.2 Content Uniformity 
 
Content uniformity study, for the implant containing sucrose, was performed using 
formulation L, Table 4, with a lipophilic and a hydrophilic dye solution of 2.5 % w/w, Sudan 
III (Asmus, Gurny, & Möller, 2011) and Methylene Blue (Hyun, 2015), respectively. The 
formulation J, containing Gelucire 50/02 instead of Sucrose, had already been evaluated by our 
group in a previous work (Antunes, 2015). 
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3.9.3 In vitro Drug Release 
 
Implants, n=5, were placed in 1.5 mL PBS pH 7.4 with 0.01 % w/w sodium azide at 
37 C with 0.3 x g. At predetermined time points, the medium was completely replaced with 
fresh PBS pH 7.4 and the drug content was measured by UV-Vis spectrophotometry. Sink 
conditions were kept in all experiments. 
 
3.9.4 Drug Content 
 
Implants were crushed and dispersed in 25 mL of absolute ethanol. Salicylic acid was 
completely dissolved, whereas implant excipients were dispersed. An aliquot was filtered, 
diluted and then drug quantification was performed by UV-Vis spectrophotometry at 295 nm, 
wavelength of maximum absorption for salicylic acid in absolute ethanol. 
 
 
3.10. Statistical analysis 
 
Differences in mean values of the results were evaluated by one-way analysis of 
variance, ANOVA, followed by Tukey's multiple comparison test. Values were expressed as 
mean ± standard deviation, SD. The differences between individual means were significant with 
at * p<0.05, ** p<0.01 and *** p<0.001. 
All analyses were performed using GraphPad Prism 5® by GraphPad Software, USA.  
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4. Results and Discussion 
 
In this work, caffeine and salicylic acid were used as hydrophilic and lipophilic 
models, respectively, and five ILs, three imidazole-based, [C2mim][Br], [C4mim][Br] and 
[C6mim][Br], and two choline-based, [Cho][Phe] and [Cho][Glu], were investigated as 
solubility and permeation promotors for both actives. The ability of ILs to enhance drug release 
from lipidic implants, was also explored. 
The imidazole-based ILs, [C2mim][Br], [C4mim][Br] and [C6mim][Br], were kindly 
provided by CQB of  Faculdade de Ciências da Universidade de Lisboa. 
For the preparation of the two choline-based ILs derived from amino acids, small 
modifications were implemented to the synthesis already described in the literature (Gouveia 
et al., 2014), which allowed to afford higher yields (by 13% for [Cho][Glu] and by 20% for 
[Cho][Phe]). All studied ILs, shown in Figure 4, were viscous liquids at room temperature, 
with the exception of [C2mim][Br] which was a white solid. The 1H-NMR spectroscopic data 
of the prepared ILs, [Cho][Glu] and [Cho][Phe], presented in Appendix I, are in agreement 
with previously described obtained data (Czekanski et al., 2014; Gouveia et al., 2014). 
 
Figure 4: Structure of the studied ILs (Santos de Almeida et al., 2017). 
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4.1. Solubility Studies 
 
Water is one of the most commonly employed solvents for pharmaceutical 
formulations. Hence, the influence of the prepared ILs on the solubility of caffeine and salicylic 
acid was evaluated in water. For this purpose, the solubility of caffeine and salicylic acid in 
water or in water:IL mixtures, in a proportion of 95:5, was evaluated at 25 C and at 32 C, as 
shown in Figure 5. Caffeine and salicylic acid solubility in deionized water at 25 C were 20.02 
± 0.07 mg/mL and 2.07 ± 0.03 mg/mL, respectively, these results agree with the literature (Dias, 
Hadgraft, & Lane, 2007; Sigma-Aldrich, 2017). 
For both studied actives, the choline-based ILs proved to be the best solubility 
enhancers. Nonetheless, this outcome was more significant for caffeine than for salicylic acid. 
In fact, for caffeine and when using the choline-based ILs, a two-fold solubility increase was 
observed at 25 C and three-fold at 32 °C. With the imidazole-based ILs, results showed that 
[C6mim][Br] was the best solubility enhancer for caffeine. For Salicylic Acid, no significant 
differences in solubility were observed, in the presence of the imidazole-based ILs.  
  
 
Figure 5: A. Caffeine and B. Salicylic acid solubility in water or water:IL mixtures, 95:5, % w/w, at 25 C and 32 
C. n=3, mean ± SD and * p<0.05, ** p<0.01, *** p<0.001 in ANOVA, Tukey’s Test. 
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Considering that the major solubility enhancement is observed for caffeine and in the 
presence of the less cytotoxic choline-based ILs, further solubility studies were carried out with 
this active in several concentrations of both ILs—0.1, 0.2, 0.5, 1.0, 3.0 and 5.0 % w/w—at both 
temperatures. These studies are shown in Figure 6 and 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Caffeine solubility in different concentrations, % w/w, of the choline-based ILs at 25 C. n=3, mean ± 
SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Caffeine solubility in different concentrations, % w/w, of the choline-based ILs at 32 C. n=3, mean ± 
SD. 
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Once again, it was confirmed that caffeine solubility was higher in the presence of the 
ILs at all studied IL concentrations, and that at concentrations of IL higher than 1.0 % w/w, 
[Cho][Phe] was the best solubility enhancer at both temperatures. 
Results also showed that caffeine solubility was greatly influenced by the ILs 
concentrations up to 0.5 % w/w and that at higher concentrations, even though the solubility 
continues to slightly increase, it was much less dependent on the IL content. This result 
evidences that even low concentrations of ILs impact caffeine solubility, which is particularly 
relevant since it shows that at non-toxic concentrations of IL, 0.2 % w/w, the desired 
enhancement in drug solubility is still achieved, has shown in Figure 6 and 7, and more 
particularly in Table 5. 
 
Table 5: Caffeine solubility in water or water:ILs mixtures, 99.8:0.2 % w/w, at 25 C and 32 C.  n=3, mean ± 
SD. 
Solvent 
Solubility, mg/mL 
25 ºC 32 ºC 
Mean SD mean SD 
Water 20.02 0.07 22.36 0.17 
Water:[Cho][Glu] 25.69 0.02 29.67 0.35 
Water: [Cho][Phe] 25.87 0.07 35.73 0.38 
 
 
 
4.2. Permeation Studies 
 
To investigate the influence of the prepared ILs on the studied actives permeation, 
solutions were used with drug excess as donor phases since their chemical potential is equal 
and a constant driving force is maintained. Additionally, in a system where the barrier properties 
of the membrane are unaffected by the vehicle and/or permeating solvent, the flux from a 
saturated solution will be independent from them (Rosado, Cross, Pugh, Roberts, & Hadgraft, 
2003; Twist & Zatz, 1986). 
For caffeine, the highest flux was observed with the more hydrophobic IL, 
[C6mim][Br]. Once again, dependence between permeation and the IL’s alkyl chain size was 
noted amongst the imidazole-based ILs at Figure 8A. These results may be due to an increase 
in the caffeine partition membrane and/or an increase in diffusion. For salicylic acid, results 
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show that the permeation was slightly improved in the presence of [C6mim][Br] or 
[C2mim][Br], as it could be seen at Figure 8B. This may be due to [C2mim][Br] increasing the 
hydrophilicity of the vehicle, which would increase the partition of the more lipophilic permeant 
from the vehicle. On the other hand, a possible surfactant affect provided by the longer alkyl 
chain in [C6mim][Br] might have disturbed the skin membrane and thus also contributed to a 
higher flux of the active in the presence of this IL. These results can be supported with previous 
studies that say that imidazole-based ILs with alkyl chains longer than four carbons act as 
amphiphilic substances and display interface interaction (Fatemi & Izadiyan, 2011; Łuczak et 
al., 2008; Zhang et al., 2016). Significant differences in the permeation of the two model actives 
were not observed for the choline-based ILs. This may be an advantage, when a low permeation 
and a high solubility of the drug is sought, thus guaranteeing a lower incidence of adverse 
effects in topical formulations. 
 
 
Figure 8: Relative permeation flux of saturated solutions of A. Caffeine and B. Salicylic acid in water or water:IL 
mixtures, 95:5 % w/w. 3 < n < 5, mean ± SD and **p<0.01 and ***p<0.001 with ANOVA, Tukey’s test. 
 
Nonetheless, to further assess which ILs may be more suitable as functional 
ingredients in DDS, it is necessary to evaluate their cytotoxicity, to understand their 
functionality at non-toxic concentrations. 
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4.3. Ionic Liquids Cytotoxicity 
 
The cytotoxicity of the five studied ILs was characterized in human keratinocytes, 
HaCat cells. All ILs showed a clear concentration-dependent cytotoxicity, as shown in Figures 
9 and 10.  
 
 
Figure 9: Cell viability of HaCat cells exposed to halogenated ILs during 24 h of incubation, MTT assay. Results 
are presented as mean ± SD, n=2. 
 
 
 
Figure 10: Cell viability of HaCat cells exposed to choline-based ILs during 24 h of incubation, MTT assay. 
Results are presented as mean ± SD, n=2. 
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The halogenated ILs showed a clear increase in cytotoxicity associated with the length 
of the alkyl chains, has may be seen in Figure 9. The half maximal inhibitory concentration, 
IC50, values of halogenated ILs were 0.10 % V/V for hexyl, 0.30 % V/V for butyl and 0.44 % 
for ethyl analogue.  
This findings are in agreement with previously published data (Romero, Santos, Tojo, 
& Rodríguez, 2008) and may be once again explained by the enhancement in surfactancy 
provided by the longer alkyl chains (Łuczak, Hupka, Thöming, & Jungnickel, 2008), which 
might have disturbed the cell membranes. Moreover, as a consequence of increase lipophilicity, 
[C6mim][Br] might have accumulated in cells at higher levels, exhibiting a higher cytotoxicity 
when compared to the less lipophilic analogues. Additionally, our results are also in agreement 
with previously published data concerning the cytotoxicity of [C6mim][Br] and [C4mim][Br] 
in human HeLa cells (Gouveia et al., 2014). Although these previous cytotoxicity assays were 
performed in a different cell line and under distinct experimental conditions, the hexyl 
derivative also presented higher cytotoxicity than the butyl analogue. 
The two choline-based ILs, shown in Figure 10, exhibit a similar cytotoxic profile and 
proved to be less toxic than [C4mim][Br] and [C6mim][Br]. Their IC50 values were 0.43 % V/V 
for [Cho][Phe] and 0.42 % V/V for [Cho][Glu]. Furthermore, the cytotoxicity of the higher 
concentrations of amino acid derivates ILs may be ascribed to the alkaline properties of these 
ILs, which might disturb cell pH medium. 
 
 
4.4. Gravimetric studies: Determination of the Percentage 
of imidazole-based ILs that permeated the skin 
 
Since the halogenated ILs proved to be the most toxic ILs, it became relevant in this 
study to understand how much of these ILs permeated through the skin. 
Gravimetric results, presented in Table 6, show that the more lipophilic [C6mim][Br] 
is, amongst the imidazole-based ILs, the IL that presents a higher permeation through the skin. 
Results also show that the longest the alkyl chain the higher these ILs permeate through the 
skin. This may be due to an enhancement of the ILs surfactant capacity, that may increase the 
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skin instability and thus promote the ILs’ permeation. It should also be mentioned that for the 
more toxic [C4mim][Br] and [C6mim][Br] ILs, the permeation percentage is quite high, above 
80 %, which reveals that it is fundamental to consider their cytotoxicity results when 
considering their use in topical delivery systems, since most of these ILs content will permeate 
the skin. 
 
Table 6: Percentage, %, of imidazole-based ILs that permeated the skin. n=3 and mean ± SD. 
Ionic Liquid 
IL permeation % 
Mean SD 
[C2mim][Br] 67.1 4.3 
[C4mim][Br] 83.8 5.7 
[C6mim][Br] 91.1 3.2 
 
 
 
4.5. Topical Formulations: Preparation and Stability 
Studies 
 
Within this study, 2.0 % w/w of caffeine, was incorporated into O/W emulsions and 
gels, in the presence or absence of the less toxic choline-based ILs, at an IL percentage that did 
not exhibit a marked decreased in cell viability, 0.2 % w/w. 
 
 
4.5.1.  O/W Emulsions 
 
O/W emulsions proved to be stable regarding pH value, viscosity and organoleptic 
characteristics after the performed accelerated stability studies, as shown in Table 7.  
Results showed that the formulations containing ILs had a lower viscosity, thus 
indicating that the ILs modified the rheology, which may be correlated with their properties as 
solvents (Anderson, Pino, Hagberg, Sheares, & Armstrong, 2003; Carda-Broch, Berthod, & 
Armstrong, 2003), since they have the capacity to dissolve both inorganic and organic 
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compounds. Additionally, O/W emulsions containing [Cho][Glu] required a larger amount of 
Crodafos CES®, 6.0 %, to stabilize the formulation, since this IL had a higher impact in 
decreasing the viscosity than [Cho][Phe], as shown in Table 7. Nevertheless, this change did 
not alter the pH values of the prepared samples and the used amount of Crodafos CES® was far 
from the upper usage limit. 
 
Table 7: Temperatures cycles, n=3, for the O/W emulsions. 
% Crodafos 
CES® 
Formulation 
Time Zero Time Five 
pH 
Viscosity, 
mPa.s 
pH 
Viscosity, 
mPa.s 
4 
Without caffeine/IL 4.99 10 260 5.00 11 503 
With caffeine without IL 5.00 13 160 4.99 14 000 
With caffeine and [Cho][Phe] 4.99 12 630 4.99 12 900 
6 
Without caffeine/IL 4.99 17 130 5.00 19 100 
With caffeine and without IL 4.99 22 100 4.98 25 600 
With caffeine and [Cho][Glu] 5.00 19 200 5.01 22 030 
 
 
 
4.5.2. Gels 
 
To broaden the applicability of the choline-based ILs in different formulations, gels 
containing caffeine were also prepared. In this case, there was an observable difference in visual 
appearance when the active and the ILs were incorporated. The gel without caffeine or IL 
presented a translucent appearance with some air bubbles, possibly due to the incorporation of 
air during the preparation. In the presence of the drug and without IL, caffeine crystals were 
macroscopically observed. On the other hand, in the presence of caffeine and IL, the gel lost 
some transparency, which may be due to a decreased solubility of the polymer. However, 
caffeine crystals were not macroscopically and microscopically observable (data not shown), 
attesting that the ILs also enhanced the drug incorporation into the gels. Concerning the 
viscosity, a slight decrease was only detected in the gels containing the [Cho][Phe], but with no 
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impact on the gels stability. Stability results showed once again that the presence of ILs allowed 
a higher caffeine loading while maintain the gels stability, as shown in Table 8. 
 
Table 8: pH and viscosity of the gels with and without caffeine and/or the choline-based ILs. 
Formulation pH Viscosity, mPa.s 
Without caffeine/IL 5.51 118 000 
With caffeine without IL 5.52 122 000 
With caffeine and [Cho][Phe] 5.45 117 000 
With caffeine and [Cho][Glu] 5.46 123 000 
 
 
 
4.6. Microscopic Analysis 
 
Microscopic analysis showed that the incorporation of 2.0 % w/w of caffeine, in the 
absence of IL, resulted in drug crystallization after emulsion preparation, as shown in Figure 
11. This is agreement with the caffeine solubility, which was determined to be 20 mg/mL in 
water at 25 C, since a drug loading of 2.0 % w/w in the emulsion, represents a higher 
percentage of drug concentration in the aqueous phase, thus justifying the presence of crystals 
in the absence of the ILs. When the ILs were added to the aqueous phase of the emulsion, no 
drug crystals were visible, as may be seen in Figure 11, thus showing a higher drug 
incorporation into the emulsions containing ILs. 
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Figure 11: Microscopic analysis of O/W emulsions with and without caffeine and/or the IL: A. [Cho][Phe];       
B.[Cho][Glu]. Arrows point to visible caffeine crystals. Scale bar = 100 µm. 
 
 
4.7. Lipidic Implants 
 
Lipidic implants present a great potential as parenteral controlled drug delivery 
systems since they provide drug protection, accurate and targeted release (Koennings et al., 
2006; Kreye et al., 2008; Schwab, Sax, Schulze, & Winter, 2009). However, lipid implants have 
some disadvantages, such as inflexible drug release profiles, making it crucial to find ways to 
overcome this drawback. In this sense, the incorporation of ILs in these systems may be relevant 
to overcome this problem. In this context, in a previous work, developed by our group (Antunes, 
2015), it was possible to show that the presence of IL may influence drug release from lipidic 
implants containing caffeine, a more hydrophilic drug. Following this, and to evaluate if ILs 
may also influence the release profile of lipophilic drugs, in the present study salicylic acid was 
incorporated in lipidic implants with or without IL and the performance of these systems was 
evaluated.  
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4.7.1. Content Uniformity 
 
To evaluate if the incorporation of hydrophilic or lipophilic compounds influences the 
solids content of the prepared implants containing sucrose, in the presence of ILs, a content 
uniformity study was performed for formulation L, presented in Table 4. 
All implants presented a homogeneous and even surface and dimensions were defined 
as 0.1 cm of diameter and 0.5 cm of length. 
In the Content Uniformity assays, it was observed a great diffusion of both dyes 
solution in the lipidic implant, as shown in Figure 12. The studied implants presented a 
homogeneous dispersion in all batch. Thus, the results proved that this delivery system 
containing sucrose and ILs may be used to incorporate both hydrophilic and lipophilic drugs 
and, which is in agreement with previous work, that evaluated the content uniformity of lipidic 
implants containing Gelucire 50/02 and ILs (Antunes, 2015). 
      
Figure 12: Lipidic Implants with 2.5 % w/w of A. Sudan III or B. Methylene Blue. 
 
4.7.2. In Vitro Drug Release 
 
The main goal of incorporating ILs in lipidic implants was to evaluate their influence 
in drug delivery. As shown in Figure 13, there was an initial burst release due to drug present 
at the surface of the implant, followed by a zero-order release profile. Also, the shape of the 
curves did not change, so the in vitro drug release’s mechanism was equal for all batches.  
The lowest release was observed in the presence of Dynasan 118®, which could be 
explained by its high lipophilicity and low wettability (Amaral, 2016; Antunes, 2015). These 
two characteristics may hinder the salicylic acid release, since it is a lipophilic drug and it is 
more comfortable for this drug to stay in the implant than to be release to a lipophobic medium, 
such as PBS. It is also relevant to mention that the drug release performance of the formulation 
A B 
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containing Dynasan 118® and Sucrose, was similar to the formulation only containing Dynasan 
118®. 
However, formulations contaning Gelucire 50/02, both with and without IL, presented 
the highest drug release. These results may be a consequence of Gelucire 50/02 being a release 
promotor and allowing the implant to degrade over time. The lower release of Dynasan 
118:Gelucire 50/02:IL than Dynasan 118:Gelucire 50/02 may be due to an interaction between 
the drug and the implant containing IL, which shows that the presence of ILs may influence the 
drug release as desired. 
Furthermore, when concerning formulations with Sucrose, these presented a lower 
drug release than Gelucire 50/02, despite Sucrose being more degradable, which was noticeble 
since the implants were more fragmented in the end of the study, the drug release was lower 
than for the implants containing Gelucire 50/02. This result shows that using sucrose has a 
higher influence on the implants degradability, but not on drug release. 
Finally, in general results showed that the presence of the IL enhances drug release, 
because all formulations containing IL had higher drug release when compared with the 
formulation containing Dynasan 118® alone.   
 
Figure 13: Effect of implants composition on drug release, mean ± SD and n=5. 
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4.7.3. Drug Content 
 
Results showed an appropriate content uniformity and a satisfactory homogeneity in 
all batches containing salicylic acid, as shown in Figure 14, where no statically significant 
differences were observed in the drug content for all the studied batches.  
 
Figure 14: Drug content of the prepared implants with A.Dynasan 118, B. Dynasan 118:IL, C. Dynasan 
118:Gelucire 50/02, D. Dynasan 118:Gelucire 50/02:IL, E. Dynasan 118:Sucrose and F. Dynasan 118:Gelucire 
50/02:IL. n=3 and mean ± SD. Statistically analysed by ANOVA, Tukey’s test. 
 
  
Ana Luísa Gomes Júlio   Ionic liquids as functional ingredients in drug delivery systems: 
                                                                            solubility, permeation and cytotoxicity studies 
44 
Universidade Lusófona de Humanidades e Tecnologias, Escola de Ciências e Tecnologias da Saúde 
 
5. Conclusion 
 
Five different ILs were studied—three imidazole-based ILs, [C2mim][Br], 
[C4mim][Br] and [C6mim][Br], and two choline-based ILs, [Cho][Phe] and [Cho][Glu]—as 
solubility and/or permeation promotors of the hydrophilic and lipophilic active models, caffeine 
and salicylic acid respectively. The influence of the ILs on drug release from lipidic implants 
was also evaluated. 
The choline-based ILs proved to be the best solubility promoters for both actives, 
although a more prominent effect was observed for the more hydrophilic caffeine. It was also 
shown that lower concentrations of these ILs, up to 0.5 % w/w, had a higher influence on 
caffeine solubility. Regarding permeation, the choline based ILs showed no significant impact 
on the skin permeation, for both actives. This fact may be useful to guarantee a lower incidence 
of adverse effects in topical formulations where low permeation of the active is sought.  
For the halogenated ILs, it was observed that the size of the alkyl chain impacted their 
ability to enhance the caffeine solubility and permeation. When concerning salicylic acid, these 
ILs did not impact the drug solubility. On the other hand, for this active, drug permeation was 
enhanced in the presence of both [C2mim][Br] and [C6mim][Br], while [C4mim][Br] showed 
no impact on this parameter. Nonetheless, the alkyl chain length also influenced the ILs 
cytotoxicity, with the [C6mim][Br] presenting the higher cytotoxicity. [Cho][Phe] and 
[Cho][Glu] showed lower cytotoxicity when compared with [C4mim][Br] and [C6mim][Br]. 
Because of the higher toxicity of the imidazole-based ILs, it was also evaluated the 
amount of these ILs that permeated through the skin through gravimetric studies. Results 
showed that the longest the alkyl chain the more this ILs permeate through the skin, probably 
be due to an enhancement of the ILs surfactant capacity.  
Furthermore, for the more toxic [C4mim][Br] and [C6mim][Br] ILs, the permeation 
percentage is higher than 80%, revealing that it is vital to consider their cytotoxicity when 
considering their use Drug delivery systems. 
Results clearly showed that between the imidazole- and the choline-based ILs, the 
latter are more suitable to incorporate into drug delivery systems, since they had higher impact 
in drug solubility and had a lower cytotoxicity. Also, since a more prominent enhancement in 
solubility was observed for caffeine with the less cytotoxic [Cho][Phe] and [Cho][Glu] ILs, 
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O/W emulsions and gels were prepared containing this more hydrophilic active and choline-
based ILs.  
When preparing the topical formulations, it was considered the IL percentage that did 
not exhibit a marked decrease in cell viability. All prepared emulsions and gels were stable after 
stress stability studies, which was a good indicative that the choline-based ILs did not 
negatively affect the integrity of the prepared topical formulations. 
Finally, lipidic implants, in the presence and absence of ILs, were successfully 
prepared and drug content uniformity was achieved. In general implants containing ILs 
presented a higher drug release.  
In conclusion, this study clearly shows that the less toxic choline-based ILs, are better 
suited as functional ingredients in drug delivery systems. This statement was proven since even 
at low non-toxic concentrations, these salts enhanced drug solubility and facilitated the 
incorporation of higher drug concentrations in topical formulations, while keeping their 
organoleptic properties, stability and safety and they also led to a higher drug release from 
lipidic implants while maintaining a drug content uniformity. 
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7. Glossary 
 
Choline-based Ionic Liquids: ionic liquids in which the cation is choline. 
 
Drug Delivery System: a formulation or a medical device that introduces the drug in 
the body and increases the efficacy and safety of the drug controlling the rate, time and 
place of its release. 
 
Halogenated Ionic Liquids: ionic liquids in which the anion is a halogen. 
 
Imidazole-based Ionic Liquids: ionic liquids in which the cation is imidazolium. 
 
Ionic Liquids: salts with organic cation and an organic or inorganic anion. 
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Appendix I: 1H-NMR Spectrums of the Synthetized Choline-
based ILs 
 
 
Figure 15: 1H NMR Spectrum of the synthetized [Cho][Glu]. 
 
 
Figure 16: 1H NMR Spectrum of the synthetized [Cho][Phe]. 
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Appendix II: Physical and Chemical Properties of the Model 
Drugs  
 
Active 
Molecular 
Formula 
Molecular 
Weight, 
g/mol 
Melting 
Point, C 
Density, 
g/cm3 
Water 
Solubility at 
25 C, 
mg/mL 
Caffeine C8H10N4O2
 a 194.19 a 238 a 1.23 a 20.02 ± 0.07b 
Salicylic 
Acid 
C7H6O3
c 138.12 c 158 c 1.44 c 2.07 ± 0.03 c 
a. Sigma-Aldrich, 2017a; b. Dias et al., 2007; c. Sigma-Aldrich, 2017b 
 
